BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

45 related articles for article (PubMed ID: 2430407)

  • 1. The perivascular cell populations in human skin after topical application of leukotriene B4.
    Winkelmann RK; Camp R; English JS; Greaves MW
    Acta Derm Venereol; 1986; 66(4):340-3. PubMed ID: 2430407
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Characteristics of the cellular response of the rat conjunctiva to topically applied leukotriene B4.
    Trocmé SD; Gilbert CM; Allansmith MR; Bloch KJ; Abelson MB
    Ophthalmic Res; 1989; 21(4):297-302. PubMed ID: 2555760
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The responses of normal and psoriatic skin to single and multiple topical applications of leukotriene B4.
    Wong E; Camp RD; Greaves MW
    J Invest Dermatol; 1985 May; 84(5):421-3. PubMed ID: 2987362
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Leukotriene B4-induced accumulation of polymorphonuclear leukocytes in psoriatic skin.
    van de Kerkhof PC; Lammers AM; Mier PD; Happle R
    Adv Prostaglandin Thromboxane Leukot Res; 1987; 17B():637-9. PubMed ID: 2823562
    [No Abstract]   [Full Text] [Related]  

  • 5. Topical application of clobetasol-17-propionate inhibits the intra-epidermal accumulation of polymorphonuclear leukocytes.
    Chang A; van de Kerkhof PC
    Acta Derm Venereol; 1988; 68(1):57-60. PubMed ID: 2449013
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Leukotriene B4 mediates substance P-induced granulocyte infiltration into mouse skin. Comparison with antigen-induced granulocyte infiltration.
    Iwamoto I; Tomoe S; Tomioka H; Yoshida S
    J Immunol; 1993 Aug; 151(4):2116-23. PubMed ID: 7688393
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Priming of eosinophil recruitment in vivo by LPS pretreatment.
    Macari DM; Teixeira MM; Hellewell PG
    J Immunol; 1996 Aug; 157(4):1684-92. PubMed ID: 8759756
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sequential patterns of inflammatory events during developing and expressed skin late-phase reactions.
    Zweiman B; Haralabatos IC; Pham NC; David M; von Allmen C
    J Allergy Clin Immunol; 2000 Apr; 105(4):776-81. PubMed ID: 10756229
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Leukotriene B4: an inflammatory mediator with vascular actions in vivo.
    Bray MA
    Agents Actions Suppl; 1982; 11():51-61. PubMed ID: 6295113
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Response of polymorphonuclear leukocytes to topical leukotriene B4 in healthy and psoriatic skin.
    Lammers AM; van de Kerkhof PC
    Br J Dermatol; 1987 Apr; 116(4):521-4. PubMed ID: 3034322
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of the generation in vitro of chemotactically active LTB4 and its omega-metabolites by human neutrophils and lymphocytes/monocytes.
    Rosenbach T; Czarnetzki BM
    Clin Exp Immunol; 1987 Jul; 69(1):221-8. PubMed ID: 2820638
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Enhancement by monokines of leukotriene generation by human eosinophils and neutrophils stimulated with calcium ionophore A23187.
    Dessein AJ; Lee TH; Elsas P; Ravalese J; Silberstein D; David JR; Austen KF; Lewis RA
    J Immunol; 1986 May; 136(10):3829-38. PubMed ID: 3009610
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The inter-relation between inflammation and epidermal proliferation in normal skin following epicutaneous application of leukotriene-B4--an immunohistochemical study.
    de Jong EM; van Erp PE; van Vlijmen IM; van de Kerkhof PC
    Clin Exp Dermatol; 1992 Nov; 17(6):413-20. PubMed ID: 1336720
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Leukotriene B4 enhances activation, proliferation, and differentiation of human B lymphocytes.
    Yamaoka KA; Claésson HE; Rosén A
    J Immunol; 1989 Sep; 143(6):1996-2000. PubMed ID: 2550549
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lipoxin A4 and B4 inhibit leukotriene-stimulated interactions of human neutrophils and endothelial cells.
    Papayianni A; Serhan CN; Brady HR
    J Immunol; 1996 Mar; 156(6):2264-72. PubMed ID: 8690917
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Leukotrienes: mediators of inflammation and immediate hypersensitivity reactions.
    Malmsten CL
    Crit Rev Immunol; 1984; 4(4):307-34. PubMed ID: 6325090
    [No Abstract]   [Full Text] [Related]  

  • 17. The effects of LY293111Na, a leukotriene B4 receptor antagonist, on the pulmonary neutrophilia and CD11b expression caused by inhalation of a leukotriene B4 aerosol in rhesus monkeys.
    Allen DL; Hoffman WP; Marder P; Matchett MR; Leiter PA; Abbott DL; Wolff RK
    J Pharmacol Exp Ther; 1996 Apr; 277(1):341-9. PubMed ID: 8613940
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of topical dexamethasone and topical FK506 treatment for the experimental allergic conjunctivitis model in BALB/c mice.
    Shoji J; Sakimoto T; Muromoto K; Inada N; Sawa M; Ra C
    Jpn J Ophthalmol; 2005; 49(3):205-10. PubMed ID: 15944824
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Production of intraepidermal microabscesses by topical application of leukotriene B4.
    Camp R; Jones RR; Brain S; Woollard P; Greaves M
    J Invest Dermatol; 1984 Feb; 82(2):202-4. PubMed ID: 6319504
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Four cases of tinea improved with topical leukotriene B4 application].
    Katayama H
    Nihon Hifuka Gakkai Zasshi; 1987 Sep; 97(10):1129-31. PubMed ID: 2831413
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 3.